Lasola, Emie .
HRN: 11-97-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
AMPICILLIN 1GM (VIAL)
11/22/2023
11/23/2023
IV
2 G
IVTT
PROM X 6 Hrs, MSAF Thinly
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes